Quellenverzeichnis (Teil 2 von 2)

[s114] Marra G, Sturch P, Oderda M, Tabatabaei S, Muir G, Gontero P (2016): Systematic review of lower urinary tract symptoms/benign prostatic hyperplasia surgical treatments on men's ejaculatory function: Time for a bespoke approach?. International journal of urology : official journal of the Japanese Urological Association. PMID 26177667; DOI 10.1111/iju.12866

[s115] Salinas-Casado J, Vírseda-Chamorro M, Méndez-Rubio S, Luján-Galán M, Esteban-Fuertes M, Moreno-Sierra J (2016): Prognostic factors for the efficacy of Silodosin in the treatment of symptomatic Benign Prostatic Hyperplasia. Subanalysis of the URAL study (Prognosefaktoren für die Wirksamkeit von Silodosin bei symptomatischer benigner Prostatahyperplasie. Subanalyse der URAL-Studie). Archivos espanoles de urologia. PMID 27845695

[s116] Shim SR, Kim JH, Chang IH, Shin IS, Hwang SD, Kim KH, Yoon SJ, Song YS (2016): Is Tamsulosin 0.2 mg Effective and Safe as a First-Line Treatment Compared with Other Alpha Blockers?: A Meta-Analysis and a Moderator Focused Study. Yonsei Med J:407-418. PMID 26847294; DOI 10.3349/ymj.2016.57.2.407

[s117] Takeshita H, Moriyama S, Arai Y, Washino S, Saito K, Chiba K, Horiuchi S, Noro A (2016): Randomized Crossover Comparison of the Short-Term Efficacy and Safety of Single Half-Dose Silodosin and Tamsulosin Hydrochoride in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Low Urin Tract Symptoms:38-43. PMID 26789541; DOI 10.1111/luts.12106

[s118] Yang D, Wu J, Yuan H, Cui Y (2016): The efficacy and safety of silodosin for the treatment of ureteral stones: a systematic review and meta-analysis. BMC Urol:23. PMID 27233621; DOI 10.1186/s12894-016-0141-y

[s119] Yeo JK, Choi H, Bae JH, Kim JH, Yang SO, Oh CY, Cho YS, Kim KW, Kim HJ (2016): Korean clinical practice guideline for benign prostatic hyperplasia. Investig Clin Urol:30-44. PMID 26966724; DOI 10.4111/icu.2016.57.1.30

[s120] Кириленко Е. А., Онопко В. Ф (2016): Оценка клинического применения силодозина у мужчин с симптомами нижних мочевых путей на фоне доброкачественной гиперплазии предстательной железы (Bewertung des klinischen Einsatzes von Silodosin bei Männern mit LUTS bei BPH). Тихоокеанский медицинский журнал. ohne PMID/DOI (https://cyberleninka.ru/article/n/otsenka-klinicheskogo-primeneniya-silodozina-u-muzhchin-s-simptomami-nizhnih-mochevyh-putey-na-fone-dobrokachestvennoy-giperplazii)

[s121] Сыркашева А. Г., Языкова О. И., Нодельман Е. К., Макарова Н. П., Долгушина Н. В (2016): Ретроградная эякуляция и мужской фактор бесплодия (обзор литературы) (Retrograde Ejakulation und männlicher Infertilitätsfaktor, Literaturuebersicht). Экспериментальная и клиническая урология. ohne PMID/DOI (https://cyberleninka.ru/article/n/retrogradnaya-eyakulyatsiya-i-muzhskoy-faktor-besplodiya-obzor-literatury)

[s122] Bozkurt O, Demir O, Sen V, Esen A (2015): Silodosin causes impaired ejaculation and enlargement of seminal vesicles in sexually active men treated for lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urology. PMID 25744372; DOI 10.1016/j.urology.2015.01.011

[s123] Descazeaud A, de La Taille A, Giuliano F, Desgrandchamps F, Doridot G (2015): Negative effects on sexual function of medications for the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia (Negative Wirkungen von Arzneimitteln gegen untere Harnwegssymptome bei benigner Prostatahyperplasie auf die Sexualfunktion). Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. PMID 25605342; DOI 10.1016/j.purol.2014.12.003

[s124] Sakdichod Kimsakulvech, Peerasak Suttiyotin, Anuchai Pinyopummin (2015): Dose-dependent effects of tamsulosin on the ejaculation and semen quality in bucks (Dosisabhängige Wirkungen von Tamsulosin auf Ejakulation und Samenqualität bei Böcken). Turkish Journal of Veterinary and Animal Sciences:465-471. ohne PMID/DOI (https://search.trdizin.gov.tr/tr/yayin/detay/187989)

[s125] Kimsakulvech S, Suttiyotin P, Pinyopummin A (2015): Effects of alpha1-adrenoceptor antagonist (tamsulosin) on incident of ejaculation and semen quality in the goat. Andrologia. PMID 24684217; DOI 10.1111/and.12270

[s126] Moon KH, Park CH, Jung HC, Oh TH, Kim JS, Kim DY (2015): A 12-Week, Open Label, Multi-Center Study to Evaluate the Clinical Efficacy and Safety of Silodosin on Voiding Dysfunction in Patients with Neurogenic Bladder. Low Urin Tract Symptoms:27-31. PMID 26663648; DOI 10.1111/luts.12044

[s127] Pushkar DY, Bernikov AN, Sadchenko AV (2015): SILODOSIN IN THE TREATMENT OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA--RESULTS OF RUSSIAN MULTICENTER OBSERVATIONAL STUDY (Silodosin bei der Behandlung von Patienten mit benigner Prostatahyperplasie: Ergebnisse einer russischen multizentrischen Beobachtungsstudie). Urologiia. PMID 26859934

[s128] Salinas J, Grupo URAL (2015): Clinical and urodynamic results of alpha-blocker drug treatment in patients with lower urinary tract symptoms and benign prostatic hyperplasia (Klinische und urodynamische Ergebnisse der Alphablocker-Therapie bei Patienten mit LUTS und BPH). Archivos espanoles de urologia. PMID 25774823

[s129] Sung HH, Kim JJ, Han DH, Kang SJ, Chae MR, Kim CY, Park JK, Lee SW (2015): New Methodology for Investigating Ejaculation Dysfunction: Measuring Intraluminal Seminal Vesicle Pressure in Rats with a Telemetric Device. J Sex Med:2134-2140. PMID 26503914; DOI 10.1111/jsm.13025

[s130] Tomita M, Kikuchi E, Maeda T, Kabeya Y, Katsuki T, Oikawa Y, Kato K, Ohashi M, Nakamura S, Oya M, Shimada A (2015): Clinical Background of Patients with Sperm in Their Urinary Sediment. PLoS One:e0136844. PMID 26359862; DOI 10.1371/journal.pone.0136844

[s131] Yamanishi T, Kaga K, Fuse M, Shibata C, Kamai T, Uchiyama T (2015): Six-year follow up of silodosin monotherapy for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: What are the factors for continuation or withdrawal?. Int J Urol:1143-1148. PMID 26310102; DOI 10.1111/iju.12915

[s132] Саричев Я. В (2015): ОСОБЛИВОСТІ ЗАСТОСУВАННЯ α1-АДРЕНОБЛОКАТОРІВ У ПАЦІЄНТІВ ІЗ ПЕРЕДЧАСНОЮ ЕЯКУЛЯЦІЄЮ (Besonderheiten der Anwendung von Alpha-1-Blockern bei Patienten mit vorzeitigem Samenerguss; ukrainisch). Мир медицины и биологии. ohne PMID/DOI (https://cyberleninka.ru/article/n/osoblivosti-zastosuvannya-1-adrenoblokatoriv-u-patsientiv-iz-peredchasnoyu-eyakulyatsieyu)

[s133] Castro Díaz D, Callejo D, Cortés Gil X, Pérez Hernández M (2014): Estudio de calidad de vida en pacientes con hiperplasia benigna de próstata en tratamiento con silodisina (Studie zur Lebensqualität bei Patienten mit benigner Prostatahyperplasie unter Behandlung mit Silodosin). Actas Urológicas Españolas 38(6):361-366. ohne PMID/DOI (https://dialnet.unirioja.es/servlet/articulo?codigo=4738194)

[s134] Cho HJ, Yoo TK (2014): Silodosin for the treatment of clinical benign prostatic hyperplasia: safety, efficacy, and patient acceptability. Res Rep Urol:113-119. PMID 25328864; DOI 10.2147/rru.s41618

[s135] Choi JH, Hwa JS, Kam SC, Jeh SU, Hyun JS (2014): Effects of tamsulosin on premature ejaculation in men with benign prostatic hyperplasia. World J Mens Health:99-104. PMID 25237660; DOI 10.5534/wjmh.2014.32.2.99

[s136] Descazeaud A, Davin JL, De La Taille A, Karsenty G, Karsenty G, Kouri G, et al. (2014): Evolution of lower urinary tract symptoms under silodosin: factors influencing patients' satisfaction (Entwicklung der unteren Harnwegssymptome unter Silodosin: Faktoren, die die Zufriedenheit der Patienten beeinflussen). Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. PMID 24560210; DOI 10.1016/j.purol.2013.12.002

[s137] Gacci M, Ficarra V, Sebastianelli A, Corona G, Serni S, Shariat SF, et al. (2014): Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis. The journal of sexual medicine. PMID 24708055; DOI 10.1111/jsm.12525

[s138] Kim JJ, Han DH, Sung HH, Choo SH, Lee SW (2014): Efficacy and tolerability of tamsulosin 0.4 mg in Asian patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia refractory to tamsulosin 0.2 mg: a randomized placebo controlled trial. Int J Urol:677-682. PMID 24725169; DOI 10.1111/iju.12412

[s139] Ko K, Yang DY, Lee WK, Kim SW, Moon du G, Moon KH, Park NC, Park JK, Son HC, Lee SW, Hyun JS, Park K (2014): Effect of improvement in lower urinary tract symptoms on sexual function in men: tamsulosin monotherapy vs. combination therapy of tamsulosin and solifenacin. Korean J Urol:608-614. PMID 25237463; DOI 10.4111/kju.2014.55.9.608

[s140] Moon KH, Song PH, Yang DY, Park NC, Kim SW, Lee SW, Kim SW, Moon du G, Park JK, Ahn TY, Park K (2014): Efficacy and Safety of the Selective α1A-Adrenoceptor Blocker Silodosin for Severe Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Prospective, Single-Open-Label, Multicenter Study in Korea. Korean J Urol:335-340. PMID 24868338; DOI 10.4111/kju.2014.55.5.335

[s141] Yoon S, Choi JH, Lee SH, Choi SM, Jeh SU, Kam SC, Hwa JS, Chung KH, Hyun JS (2014): Efficacy of Long-Term Daily Dosage of Alfuzosin 10 mg upon Sexual Function of Benign Prostatic Hypertrophy Patients: Two-Year Prospective Observational Study. World J Mens Health:133-138. PMID 25606561; DOI 10.5534/wjmh.2014.32.3.133

[s142] Спивак Л. Г (2014): Α1-АДРЕНОБЛОКАТОРЫ В ЛЕЧЕНИИ ХРОНИЧЕСКОГО ПРОСТАТИТА И СВЯЗАННЫХ С НИМ НАРУШЕНИЙ ФЕРТИЛЬНОСТИ (Alpha-1-Blocker bei chronischer Prostatitis und damit verbundenen Fertilitätsstörungen). Consilium Medicum 16(7):7-10. ohne PMID/DOI (https://cyberleninka.ru/article/n/1-adrenoblokatory-v-lechenii-hronicheskogo-prostatita-i-svyazannyh-s-nim-narusheniy-fertilnosti)

[s143] Akin Y, Gulmez H, Ates M, Bozkurt A, Nuhoglu B (2013): Comparison of alpha blockers in treatment of premature ejaculation: a pilot clinical trial. Iranian Red Crescent medical journal. PMID 24693363; DOI 10.5812/ircmj.13805

[s144] Ding H, Du W, Hou ZZ, Wang HZ, Wang ZP (2013): Silodosin is effective for treatment of LUTS in men with BPH: a systematic review. Asian J Androl:121-128. PMID 23223034; DOI 10.1038/aja.2012.102

[s145] Giuliano F, Droupy S (2013): Sexual side effects of pharmacological treatments (Sexuelle Nebenwirkungen pharmakologischer Behandlungen). Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. PMID 23830275; DOI 10.1016/j.purol.2013.01.008

[s146] Giuliano F, Oelke M, Jungwirth A, Hatzimouratidis K, Watts S, Cox D, et al. (2013): Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind study. The journal of sexual medicine. PMID 23346990; DOI 10.1111/jsm.12039

[s147] Jo HW, Yoo DS, Ju HT, Whang HW, Park J, Kim ET, Kim DK, Woo SH (2013): Effect of patient-optimized doses of tamsulosin on erectile function in men with erectile dysfunction and lower urinary tract symptoms. Korean J Urol:100-105. PMID 23550146; DOI 10.4111/kju.2013.54.2.100

[s148] Kim SW, Lee WC, Kim MT, Ko K, Lee WK, Lee CH, Kim JJ, Yang DY (2013): Effects of low-dose tamsulosin on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Korean J Urol:697-702. PMID 24175045; DOI 10.4111/kju.2013.54.10.697

[s149] Kogan MI, Kireev AIu (2013): Results of treatment of patients with prostatic adenoma using silodosin based on an assessment of the phenotype of male sexuality (Behandlungsergebnisse bei Patienten mit Prostataadenom unter Silodosin auf Grundlage der Bewertung des Phänotyps der männlichen Sexualität). Urologiia. PMID 24649766

[s150] Montorsi F (2013): Profile of silodosin (Profil von Silodosin). Urologiia. PMID 23789376

[s151] Rigot JM, Marcelli F, Giuliano F (2013): Ejaculatory disorders except premature ejaculation, orgasmic disorders (Ejakulationsstörungen außer vorzeitiger Ejakulation, Orgasmusstörungen). Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. PMID 23830260; DOI 10.1016/j.purol.2013.01.011

[s152] Samplaski MK, Lo K, Grober E, Jarvi K (2013): Finasteride use in the male infertility population: effects on semen and hormone parameters. Fertility and sterility. PMID 24012200; DOI 10.1016/j.fertnstert.2013.07.2000

[s153] Seyam R (2013): A systematic review of the correlates and management of nonpremature ejaculatory dysfunction in heterosexual men. Therapeutic advances in urology. PMID 24082920; DOI 10.1177/1756287213497231

[s154] Shelbaia A, Elsaied WM, Elghamrawy H, Abdullah A, Salaheldin M (2013): Effect of selective alpha-blocker tamsulosin on erectile function in patients with lower urinary tract symptoms due to benign prostatic hyperplasia. Urology. PMID 23711438; DOI 10.1016/j.urology.2013.03.026

[s155] Wu YJ, Dong Q, Liu LR, Wei Q (2013): A meta-analysis of efficacy and safety of the new α1A-adrenoceptor-selective antagonist silodosin for treating lower urinary tract symptoms associated with BPH. Prostate Cancer Prostatic Dis:79-84. PMID 22986578; DOI 10.1038/pcan.2012.36

[s156] Yamaguchi K, Aoki Y, Yoshikawa T, Hachiya T, Saito T, Takahashi S (2013): Silodosin versus naftopidil for the treatment of benign prostatic hyperplasia: a multicenter randomized trial. Int J Urol:1234-1238. PMID 23731168; DOI 10.1111/iju.12160

[s157] Yoshimura K, Kadoyama K, Sakaeda T, Sugino Y, Ogawa O, Okuno Y (2013): A survey of the FAERS database concerning the adverse event profiles of α1-adrenoreceptor blockers for lower urinary tract symptoms. Int J Med Sci:864-869. PMID 23781132; DOI 10.7150/ijms.5892

[s158] Вишневский А. Е., Лукьянов И. В., Марков А. В (2013): Предпочтения пациентов в выборе альфа-адреноблокаторов при лечении расстройств мочеиспускания у больных ДГПЖ (Patientenpräferenzen bei der Wahl von Alpha-Blockern bei BPH). Экспериментальная и клиническая урология. ohne PMID/DOI (https://cyberleninka.ru/article/n/predpochteniya-patsientov-v-vybore-alfa-adrenoblokatorov-pri-lechenii-rasstroystv-mocheispuskaniya-u-bolnyh-dgpzh)

[s159] Chapple ChR, Montorsi F, Tammela TL, Wirth M, Koldewijn E, Fernandez Fernandez E (2012): Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe (Silodosin-Therapie bei Symptomen der unteren Harnwege bei Männern mit Verdacht auf benigne Prostatahyperplasie: Ergebnisse einer internationalen, randomisierten, doppelblinden, placebo- und aktiv kontrollierten klinischen Studie in Europa). Urologiia. PMID 23342615

[s160] Cui Y, Zong H, Zhang Y (2012): The efficacy and safety of silodosin in treating BPH: a systematic review and meta-analysis. Int Urol Nephrol:1601-1609. PMID 22914879; DOI 10.1007/s11255-012-0261-6

[s161] Hwang TI, Chu SH, Lin MS, Chen CS, Lee LM, Chang HC, Yeh SD, Chen WH, Chiang PH (2012): Impact of alfuzosin on sexual function in Taiwanese men with benign prostatic hyperplasia. Kaohsiung J Med Sci:429-434. PMID 22892164; DOI 10.1016/j.kjms.2012.02.013

[s162] Lin KH, Lin YW, Wen YC, Lee LM (2012): Efficacy and safety of orally disintegrating tamsulosin tablets in Taiwanese patients with benign prostatic hyperplasia. Aging Male:246-252. PMID 23067262; DOI 10.3109/13685538.2012.724741

[s163] Sakata K, Morita T (2012): Investigation of ejaculatory disorder by silodosin in the treatment of prostatic hyperplasia. BMC urology. PMID 23082785; DOI 10.1186/1471-2490-12-29

[s164] Sato Y, Tanda H, Nakajima H, Nitta T, Akagashi K, Hanzawa T, et al. (2012): Silodosin and its potential for treating premature ejaculation: a preliminary report. International journal of urology : official journal of the Japanese Urological Association. PMID 22188258; DOI 10.1111/j.1442-2042.2011.02941.x

[s165] Tatemichi S, Kobayashi K, Yokoi R, Kobayashi K, Maruyama K, Hoyano Y, Kobayashi M, Kuroda J, Kusama H (2012): Comparison of the effects of four α1-adrenoceptor antagonists on ejaculatory function in rats. Urology:486.e9-16. PMID 22676952; DOI 10.1016/j.urology.2012.01.039

[s166] Chi BH, Kim SC (2011): Changes in sexual function in benign prostatic hyperplasia patients taking dutasteride: 1-year follow-up results. Korean J Urol:632-636. PMID 22025960; DOI 10.4111/kju.2011.52.9.632

[s167] Homma Y, Gotoh M, Yokoyama O, Masumori N, Kawauchi A, Yamanishi T, Ishizuka O, Seki N, Kamoto T, Nagai A, Ozono S, Japanese Urological Association (2011): Outline of JUA clinical guidelines for benign prostatic hyperplasia. Int J Urol:741-756. PMID 22050351; DOI 10.1111/j.1442-2042.2011.02860.x

[s168] Kogan MI, Kireev AIu (2011): Efficacy of prostatic adenoma treatment with alfusozine depending on sexuality (Wirksamkeit der Behandlung des Prostataadenoms mit Alfuzosin in Abhängigkeit von der Sexualität). Urologiia. PMID 21500491

[s169] Masumori N (2011): Naftopidil for the treatment of urinary symptoms in patients with benign prostatic hyperplasia. Ther Clin Risk Manag:227-238. PMID 21753885; DOI 10.2147/tcrm.s13883

[s170] Roehrborn CG, Kaplan SA, Lepor H, Volinn W (2011): Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH. Prostate cancer and prostatic diseases. PMID 21135869; DOI 10.1038/pcan.2010.46

[s171] Seo DH, Kam SC, Hyun JS (2011): Impact of lower urinary tract symptoms/benign prostatic hyperplasia treatment with tamsulosin and solifenacin combination therapy on erectile function. Korean J Urol:49-54. PMID 21344031; DOI 10.4111/kju.2011.52.1.49

[s172] Song SH, Son H, Kim KT, Kim SW, Moon du G, Moon KH, et al. (2011): Effect of tamsulosin on ejaculatory function in BPH/LUTS. Asian journal of andrology. PMID 21785445; DOI 10.1038/aja.2011.25

[s173] Tu HY, Zini A (2011): Finasteride-induced secondary infertility associated with sperm DNA damage. Fertility and sterility. PMID 21292254; DOI 10.1016/j.fertnstert.2010.12.061

[s174] Wada N, Numata A, Yamaguchi S, Osanai H, Mori T, Hou K, Fujisawa M, Kaneko S, Kakizaki H (2011): Optimum initial dose of silodosin for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (Optimale Anfangsdosis von Silodosin bei Symptomen der unteren Harnwege durch benigne Prostatahyperplasie). Hinyokika Kiyo:297-302. PMID 21795831

[s175] Adem Yaşar, Bekir Süha Parlaktaş, Fikret Erdemir, Fatih Fırat, Doğan Atılgan, Nihat Uluocak (2011): Benign prostat hiperplazisi tedavisinde kullanılan dört alfa blokör ajanın etkinliklerinin karşılaştırılması (Vergleich der Wirksamkeit von vier Alpha-Blockern bei BPH). Journal of Clinical and Analytical Medicine 2011:27-31. ohne PMID/DOI (https://search.trdizin.gov.tr/tr/yayin/detay/128221)

[s176] Yokoyama T, Hara R, Fukumoto K, Fujii T, Jo Y, Miyaji Y, Nagai A, Sone A (2011): Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia. Int J Urol:225-230. PMID 21272091; DOI 10.1111/j.1442-2042.2010.02708.x

[s177] Yu HJ, Lin AT, Yang SS, Tsui KH, Wu HC, Cheng CL, Cheng HL, Wu TT, Chiang PH (2011): Non-inferiority of silodosin to tamsulosin in treating patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). BJU Int:1843-1848. PMID 21592295; DOI 10.1111/j.1464-410x.2011.10233.x

[s178] Furuya R, Masumori N, Furuya S, Ogura H, Mutoh M, Kobayashi K, Hisasue S, Tsukamoto T (2010): Investigation of adverse events and the continuance rate of silodosin in all patients who received silodosin for lower urinary tract symptoms suggestive of benign prostatic hyperplasia (Untersuchung der unerwünschten Ereignisse und der Fortsetzungsrate von Silodosin bei allen Patienten, die Silodosin wegen Symptomen der unteren Harnwege bei Verdacht auf benigne Prostatahyperplasie erhielten). Nihon Hinyokika Gakkai Zasshi:13-17. PMID 20158073; DOI 10.5980/jpnjurol.101.13

[s179] Homma Y, Kawabe K, Takeda M, Yoshida M (2010): Ejaculation disorder is associated with increased efficacy of silodosin for benign prostatic hyperplasia. Urology. PMID 20472263; DOI 10.1016/j.urology.2010.03.015

[s180] Miyakita H, Yokoyama E, Onodera Y, Utsunomiya T, Tokunaga M, Tojo T, Fujii N, Yanada S (2010): Short-term effects of crossover treatment with silodosin and tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia. Int J Urol:869-875. PMID 20735791; DOI 10.1111/j.1442-2042.2010.02614.x

[s181] Shimizu F, Taguri M, Harada Y, Matsuyama Y, Sase K, Fujime M (2010): Impact of dry ejaculation caused by highly selective alpha1A-blocker: randomized, double-blind, placebo-controlled crossover pilot study in healthy volunteer men. J Sex Med:1277-1283. PMID 20102447; DOI 10.1111/j.1743-6109.2009.01663.x

[s182] Chen Y, Li H, Dong Q, Wang KJ (2009): Blockade of alpha 1A-adrenoceptor: a novel possible strategy for male contraception. Med Hypotheses:140-141. PMID 19427736; DOI 10.1016/j.mehy.2009.02.022

[s183] Hellstrom WJ, Sikka SC (2009): Effects of alfuzosin and tamsulosin on sperm parameters in healthy men: results of a short-term, randomized, double-blind, placebo-controlled, crossover study. Journal of andrology. PMID 19201696; DOI 10.2164/jandrol.108.006874

[s184] Hong YK, Park DS, Hong JY, Chung JS, Jeong SJ, Hong SK, Lee SE, Jang SH, Kim JI (2009): Clinical Trial with Tamsulosin and Doxazosin for the Treatment of Premature Ejaculation in Patients with Co-morbid LUTS: a Comparative Study. Korean J Androl 27(1):49-54. ohne PMID/DOI (https://koreamed.org/SearchBasic.php?RID=2298778)

[s185] Jung JH, Jae SU, Kam SC, Hyun JS (2009): Correlation between Lower Urinary Tract Symptoms (LUTS) and sexual function in benign prostatic hyperplasia: impact of treatment of LUTS on sexual function. J Sex Med:2299-2304. PMID 19493292; DOI 10.1111/j.1743-6109.2009.01324.x

[s186] Kaplan SA (2009): Side Effects of alpha-Blocker Use: Retrograde Ejaculation. Reviews in urology. PMID 20126607

[s187] Kobayashi K, Masumori N, Kato R, Hisasue S, Furuya R, Tsukamoto T (2009): Orgasm is preserved regardless of ejaculatory dysfunction with selective alpha1A-blocker administration. Int J Impot Res:306-310. PMID 19536124; DOI 10.1038/ijir.2009.27

[s188] Masumori N, Tsukamoto T, Iwasawa A, Furuya R, Sonoda T, Mori M, et al. (2009): Ejaculatory disorders caused by alpha-1 blockers for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: comparison of naftopidil and tamsulosin in a randomized multicenter study. Urologia internationalis. PMID 19641359; DOI 10.1159/000224868

[s189] Moon DG, Bae YD, Lee SW, Moon KH, Ahn TY, Jeong WS, Yang DY, Kim JJ, et al. (2009): The Efficacy and Safety of Tamsulosin 0.2mg/day on Sexual Function in BPH: A Multicenter Open-label, Non-comparative, 3 Months Observational, Phase IV Prospective Study. Korean J Androl 27(2):123-129. ohne PMID/DOI (https://koreamed.org/SearchBasic.php?RID=2298789)

[s190] Poirier J (2009): L'hypertrophie bénigne de la prostate et son traitement médicamenteux (Die benigne Prostatahyperplasie und ihre medikamentöse Behandlung). Mémoire (Pharmazie), Université de Lorraine. ohne PMID/DOI (https://hal.univ-lorraine.fr/hal-01734343v1)

[s191] Tsukamoto T, Endo Y, Narita M (2009): Efficacy and safety of dutasteride in Japanese men with benign prostatic hyperplasia. Int J Urol:745-750. PMID 19674165; DOI 10.1111/j.1442-2042.2009.02357.x

[s192] Yono M, Yamamoto Y, Imanishi A, Fukagawa A, Latifpour J, Yoshida M (2009): Short- and long-term effects of silodosin, a selective alpha 1A-adrenoceptor antagonist, on ejaculatory function in rats. BJU international. PMID 19220259; DOI 10.1111/j.1464-410x.2009.08364.x

[s193] Chen Y, Li H, Dong Q (2008): alpha1-adrenoceptor antagonists and ejaculation dysfunction (Alpha-1-Adrenozeptor-Antagonisten und Ejakulationsstörung). Zhonghua Nan Ke Xue:364-367. PMID 18481434

[s194] Kobayashi K, Masumori N, Hisasue S, Kato R, Hashimoto K, Itoh N, et al. (2008): Inhibition of Seminal emission is the main cause of anejaculation induced by a new highly selective alpha1A-blocker in normal volunteers. The journal of sexual medicine. PMID 18399947; DOI 10.1111/j.1743-6109.2008.00779.x

[s195] Martín-Morales A, Meyer G, Ramírez E (2008): Prevalence of ejaculatory dysfunction secondary to alpha-blocker therapy in patients with benign prostatic hyperplasia (Prävalenz von Ejakulationsstörungen infolge einer Alphablocker-Therapie bei Patienten mit benigner Prostatahyperplasie). Actas urologicas espanolas. PMID 18788486; DOI 10.1016/s0210-4806(08)73918-4

[s196] Nagai A, Hara R, Yokoyama T, Jo Y, Fujii T, Miyaji Y (2008): Ejaculatory dysfunction caused by the new alpha1-blocker silodosin: A preliminary study to analyze human ejaculation using color Doppler ultrasonography. International journal of urology : official journal of the Japanese Urological Association. PMID 18721206; DOI 10.1111/j.1442-2042.2008.02136.x

[s197] Noguchi Y, Ohtake A, Suzuki M, Sasamata M (2008): In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs. Eur J Pharmacol:256-261. PMID 18078926; DOI 10.1016/j.ejphar.2007.11.003

[s198] Amory JK, Wang C, Swerdloff RS, Anawalt BD, Matsumoto AM, Bremner WJ, et al. (2007): The effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men. The Journal of clinical endocrinology and metabolism. PMID 17299062; DOI 10.1210/jc.2006-2203

[s199] Michel MC (2007): Alpha1-adrenoceptors and ejaculatory function. British journal of pharmacology. PMID 17603543; DOI 10.1038/sj.bjp.0707369

[s200] Razumov SV, Egorov AA (2007): Expediency of switching from combined therapy with prostamol Uno and alpha-1-adrenoblockers to monotherapy with prostamol Uno in patients with prostatic adenoma (Zweckmäßigkeit des Wechsels von der Kombinationstherapie mit Prostamol Uno und Alpha-1-Adrenoblockern zur Monotherapie mit Prostamol Uno bei Patienten mit Prostataadenom). Urologiia. PMID 17724829

[s201] Sanbe A, Tanaka Y, Fujiwara Y, Tsumura H, Yamauchi J, Cotecchia S, Koike K, Tsujimoto G, Tanoue A (2007): Alpha1-adrenoceptors are required for normal male sexual function. Br J Pharmacol:332-340. PMID 17603545; DOI 10.1038/sj.bjp.0707366

[s202] Song SH, Son H, Paick JS (2007): Influence of 0.2mg Tamsulosin Treatment on the Erectile and Ejaculatory Functions in Patients with Benign Prostatic Hyperplasia. Korean J Urol 48(12):1251-1257. DOI 10.4111/kju.2007.48.12.1251

[s203] Murat Tezer, Firdovsi Memdov, Önder Canguven, Ateş Kadıoğlu (2007): BPH’de alfa bloker tedavisi ve cinsel işlevlere etkileri (Alpha-Blocker-Therapie bei BPH und Auswirkungen auf die Sexualfunktion). Türk Üroloji Dergisi/Turkish Journal of Urology 33:24-35. ohne PMID/DOI (https://search.trdizin.gov.tr/tr/yayin/detay/71533)

[s204] Giuliano FA, Clément P, Denys P, Alexandre L, Bernabé J (2006): Comparison between tamsulosin and alfuzosin on the expulsion phase of ejaculation in rats. BJU international. PMID 16879438; DOI 10.1111/j.1464-410x.2006.06426.x

[s205] Goktas S, Kibar Y, Kilic S, Topac H, Coban H, Seckin B (2006): Recovery of abnormal ejaculation by intermittent tamsulosin treatment. The Journal of urology. PMID 16407016; DOI 10.1016/s0022-5347(05)00157-6

[s206] Grasso M, Fortuna F, Lania C, Blanco S (2006): "Ejaculatory disorders and alpha1-adrenoceptor antagonists therapy: clinical and experimental researches". Journal of translational medicine. PMID 16842616; DOI 10.1186/1479-5876-4-31

[s207] Hellstrom WJ, Sikka SC (2006): Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers. The Journal of urology. PMID 16952675; DOI 10.1016/j.juro.2006.06.004

[s208] Hisasue S, Furuya R, Itoh N, Kobayashi K, Furuya S, Tsukamoto T (2006): Ejaculatory disorder caused by alpha-1 adrenoceptor antagonists is not retrograde ejaculation but a loss of seminal emission. International journal of urology : official journal of the Japanese Urological Association. PMID 17010010; DOI 10.1111/j.1442-2042.2006.01535.x

[s209] Muto S, Kasahara H, Yokoi R, Hayashi M, Souma S, Kobayashi K, Tamura T, Murakami M, Kuroda J, Shibata N (2006): Toxicity profile of silodosin (KMD-3213) (Toxizitätsprofil von Silodosin (KMD-3213)). Yakugaku Zasshi:247-256. PMID 16518090; DOI 10.1248/yakushi.126.247

[s210] Safarinejad MR (2006): Safety and efficacy of tamsulosin in the treatment of painful ejaculation: a randomized, double-blind, placebo-controlled study. International journal of impotence research. PMID 16541114; DOI 10.1038/sj.ijir.3901466

[s211] Zhang JG, Wang YL, Ren XQ, Gao ZW, Cheng YH (2006): Sexual function of men with symptomatic benign prostatic hyperplasia and effect of Tamsulosin (Sexualfunktion von Männern mit symptomatischer benigner Prostatahyperplasie und Wirkung von Tamsulosin). Zhonghua Nan Ke Xue:723-725. PMID 16970165

[s212] Лукьянов И. В., Котов С. В (2006): Медикаментозная терапия доброкачественной гиперплазии предстательной железы и сексуальная дисфункция (Medikamentoese Therapie der BPH und sexuelle Dysfunktion). Клиницист. ohne PMID/DOI (https://cyberleninka.ru/article/n/medikamentoznaya-terapiya-dobrokachestvennoy-giperplazii-predstatelnoy-zhelezy-i-seksualnaya-disfunktsiya)

[s213] Furuya R, Hisasue S, Ogura H, Furuya S, Masumori N, Itoh N, Tsukamoto T (2005): Ejaculatory disorder by alpha-1 adrenoceptor antagonist in patients with benign prostatic hyperplasia; retrospective comparison between naftopidil and tamsulosin (Ejakulationsstörung durch Alpha-1-Adrenozeptor-Antagonisten bei Patienten mit benigner Prostatahyperplasie; retrospektiver Vergleich zwischen Naftopidil und Tamsulosin). Hinyokika Kiyo:763-766. PMID 16363711

[s214] Jia Y, Cue YG, Wang XD, Wang XH, Tong JS, Ma DZ, Cai RF, Di FS (2005): Effect of selective 5alpha-reductase inhibitor or/and testosterone undecanoate on the reproductive function of male rats (Wirkung eines selektiven 5-Alpha-Reduktase-Hemmers und/oder von Testosteronundecanoat auf die Fortpflanzungsfunktion männlicher Ratten). Zhonghua Nan Ke Xue:38-41. PMID 15704680

[s215] Tambaro S, Ruiu S, Dessi C, Mongeau R, Marchese G, Pani L (2005): Evaluation of tamsulosin and alfuzosin activity in the rat vas deferens: relevance to ejaculation delays. The Journal of pharmacology and experimental therapeutics. PMID 15470085; DOI 10.1124/jpet.104.074740

[s216] Burak Turna, Ali Rodoplu, Mehmet Umul, Barış Altay, Bülent Semerci (2005): Alt üriner sistem semptomlu hastalarda cinsel disfonksiyonun araştırılması, testosteron, leptin, kan lipidleri ile ilişkisi: Alfa bloker (Tamsulosin) tedavisi sonrası yeniden değerlendirme (Untersuchung sexueller Dysfunktion bei Patienten mit LUTS, Zusammenhang mit Testosteron, Leptin, Blutfetten: Neubewertung nach Alpha-Blocker-(Tamsulosin-)Therapie). Türk Üroloji Dergisi/Turkish Journal of Urology 31:508-515. ohne PMID/DOI (https://search.trdizin.gov.tr/tr/yayin/detay/60663)

[s217] Wang XD, Jia Y, Cui YG, Wang XH, Tong JS, Ma DZ, Cai RF, Di FS (2005): Effect of large-dosage of 5alpha-reductase inhibitors on the spermatogenesis of male rats (Wirkung hoch dosierter 5-Alpha-Reduktase-Hemmer auf die Spermatogenese männlicher Ratten). Zhonghua Nan Ke Xue:652-654. PMID 16209201

[s218] Kim SW, Lee SH, Paick JS (2004): In vivo rat model to measure hypogastric nerve stimulation-induced seminal vesicle and vasal pressure responses simultaneously. Int J Impot Res:427-432. PMID 14973527; DOI 10.1038/sj.ijir.3901187

[s219] Park JK, Kim CS, Park CH, Lee JG, Chung BH, Hong SJ, et al. (2004): Effects of Alpha 1 Adrenoceptor Antagonist Tamsulosin on Sexual Function in Patients with Benign Prostatic Hyperplasia. Korean J Androl 22(3):146-150. ohne PMID/DOI (https://koreamed.org/SearchBasic.php?RID=2298603)

[s220] Baek MK, Kim SW, Paick JS (2002): Investigation of the Validity of an in vivo Experimental Model for the Evaluation of the Therapeutic Potentials of Drugs for the Treatment of Premature Ejaculation. Korean J Urol 43(11):969. ohne PMID/DOI (https://koreamed.org/SearchBasic.php?RID=2292261)

[s221] M. Bozlu, S. Çayan, E. Doruk, E. Akbay, D. Acar, E. Erdem (2002): Alfa bloker tedavinin başarısı ile gözlenen yan etkiler arasında ilişki var mıdır? (Gibt es einen Zusammenhang zwischen dem Erfolg der Alpha-Blocker-Therapie und beobachteten Nebenwirkungen?). Türk Üroloji Dergisi/Turkish Journal of Urology 28:441-444. ohne PMID/DOI (https://search.trdizin.gov.tr/tr/yayin/detay/19555)

[s222] Debruyne F, Koch G, Boyle P, Da Silva FC, Gillenwater JG, Hamdy FC, et al. (2002): Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study (Vergleich eines Phytotherapeutikums (Permixon) mit einem Alphablocker (Tamsulosin) bei benigner Prostatahyperplasie: eine internationale randomisierte Einjahresstudie). Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. PMID 12189744

[s223] Sirinarumitr K, Johnston SD, Kustritz MV, Johnston GR, Sarkar DK, Memon MA (2001): Effects of finasteride on size of the prostate gland and semen quality in dogs with benign prostatic hypertrophy. Journal of the American Veterinary Medical Association. PMID 11330612; DOI 10.2460/javma.2001.218.1275

[s224] Overstreet JW, Fuh VL, Gould J, Howards SS, Lieber MM, Hellstrom W, et al. (1999): Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. The Journal of urology. PMID 10492183; DOI 10.1016/s0022-5347(05)68270-5

[s225] Hibi H, Yamamoto M, Miyake K (1996): Effect of alpha-blockers on epididymal sperm concentration, motility and testicular productivity in the rat. Hinyokika Kiyo:357-360. PMID 8752538

[s226] Hibi H, Yamamoto M, Miyake K (1995): Effects of alpha-blocker on sperm concentration, motility, intraluminal pressure and fluid movement in the rat cauda epididymis. The Journal of urology. PMID 7609146; DOI 10.1097/00005392-199508000-00079

[s227] Yamamoto M, Hibi H, Miyake K (1995): Comparison of the effectiveness of placebo and alpha-blocker therapy for the treatment of idiopathic oligozoospermia. Fertility and sterility. PMID 7843449; DOI 10.1016/s0015-0282(16)57375-0

[s228] Yamamoto M, Hibi H, Miyake K (1995): Effects of alpha-blocker on daily testicular sperm production and sperm concentration, motility, intraluminal pressure and fluid movement in the rat epididymis. The Tohoku journal of experimental medicine. PMID 8693484; DOI 10.1620/tjem.177.25

[s229] Ratnasooriya WD, Wadsworth RM (1994): Tamsulosin, a selective alpha 1-adrenoceptor antagonist, inhibits fertility of male rats. Andrologia. PMID 7913799; DOI 10.1111/j.1439-0272.1994.tb00766.x